Review Article
Risk Factors of Multidrug-Resistant Bacteria in Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis
Table 3
Risk factors of MDR bacteria in terms of comorbidities
| Risk factors | No. of included studies | No. of included MDROs | Heterogeneity | Synthesized results |
| Chronic lung disease [16, 17, 26, 36, 38] | 5 | 420 | I2 = 0.0%, | OR: 2.19; 95% CI: 1.51 to 3.19 | Chronic liver disease [16, 32] | 2 | 60 | I2 = 0.0%, | OR: 3.41; 95% CI: 1.55 to 7.51 | Cardiac disease [16, 38] | 2 | 97 | I2 = 57.9%, | OR: 0.67; 95% CI: 0.25 to 1.86 | Cerebral disease [33, 36, 40] | 3 | 308 | I2 = 73.2%, | OR: 2.98; 95% CI: 1.37 to 6.50 | Renal replacement therapy [15, 38, 41] | 3 | 131 | I2 = 0%, | OR: 0.78; 95% CI: 0.41 to 1.48 |
|
|
MDROs: multidrug-resistant organisms. Using random-effects model. |